Annals of Hematology

, Volume 98, Issue 3, pp 805–807 | Cite as

Structural modeling of a novel TERC variant in a patient with aplastic anemia and short telomeres

  • M. RinelliEmail author
  • E. Bellacchio
  • F. Berardinelli
  • G. Pascolini
  • P. Grammatico
  • A. Sgura
  • A. P. Iori
  • L. Quattrocchi
  • A. Novelli
  • S. Majore
  • E. Agolini
Letter to the Editor

Dear Editor,

Inherited bone marrow failure syndromes (IBMFS) are a heterogeneous group of genetic blood disorders in which there is usually some form of aplastic anemia, associated with a family history of the same disorder. In addition, patients with IBMFS have a high risk of malignancies [ 1]. Some IBMFS have excessively short telomeres at the peripheral nucleated blood cell level, referred to as telomeropathies. The discovery of loss-of-function mutations in genes of telomerase complex ( TERC and TERT) established a genetic etiology for telomere attrition in these patients [ 2, 3]. Several TERC variants, more than 40 nucleotide changes and small deletions, in patients with bone marrow failure have been described [ 4]. TERCgene, encoding the RNA component of telomerase, spans 451 nucleotides and comprises one non-coding exon that contains several conserved regions essential for its stability. Vertebrate telomerase RNA is composed by four highly conserved structural regions: pseudoknot...


Compliance with ethical standards

Clinical investigations and genetic analyses were approved by the institutional scientific board of Bambino Gesù Children’s Hospital. Informed consent was obtained from the patient.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Yu QH, Wang SY, Wu Z (2014) Advances in genetic studies of inherited bone marrow failure syndromes and their associated malignancies. Transl Pediatr 3(4):305–309Google Scholar
  2. 2.
    Yamaguchi H, Calado RT, Ly H et al (2005) Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 352(14):1413–1424CrossRefGoogle Scholar
  3. 3.
    Ortmann CA, Niemeyer CM, Wawer A, Ebell W, Baumann I, Kratz CP (2006) TERC mutations in children with refractory cytopenia. Haematologica 91(5):707–708Google Scholar
  4. 4.
    Adam MP, Ardinger HH, Pagon RA. et al. (2009). Dyskeratosis Congenita. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018. Nov 12 [updated 2016 May 26]Google Scholar
  5. 5.
    Cong YS, Wright WE, Shay JW et al (2002) Human telomerase and its regulation. Microbiol Mol Biol Rev 66(3):407–425CrossRefGoogle Scholar
  6. 6.
    Chen JL, Blasco MA, Greider CW et al (2000) Secondary structure of vertebrate telomerase RNA. Cell 100(5):503–514CrossRefGoogle Scholar
  7. 7.
    Boyraz B, Bellomo CM, Fleming MD et al (2017) A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding. Blood 128(16):2089–2092CrossRefGoogle Scholar
  8. 8.
    Vulliamy TJ, Dokal I (2007) Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie 90(1):122–130CrossRefGoogle Scholar
  9. 9.
    Lin J, Ly H, Hussain A, Abraham M, Pearl S, Tzfati Y, Parslow TG, Blackburn EH (2004) A universal telomerase RNA core structure includes structured motifs required for binding the telomerase reverse transcriptase protein. Proc Natl Acad Sci U S A 101(41):14713–14718CrossRefGoogle Scholar
  10. 10.
    Marrone A, Sokhal P, Walne A, Beswick R, Kirwan M, Killick S, Williams M, Marsh J, Vulliamy T, Dokal I (2007) Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica 92(8):1013–1020CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Laboratory of Medical GeneticsBambino Gesù Children’s HospitalRomeItaly
  2. 2.Department of ScienceUniversity “Roma Tre”RomeItaly
  3. 3.Medical Genetics, Molecular Medicine DepartmentSapienza University of Rome San Camillo-Forlanini HospitalRomeItaly
  4. 4.Department of Cell Biotechnology and HematologySapienza–University of RomeRomeItaly

Personalised recommendations